NCT06258135

Brief Summary

This study aims to investigate how GOS food supplement influences the gut-microbiome-brain axis to improve emotion regulation skills and cognition in a sample of children and adolescents (aged 6-14 years).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

February 6, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
Last Updated

February 14, 2024

Status Verified

February 1, 2024

Enrollment Period

10 months

First QC Date

February 6, 2024

Last Update Submit

February 6, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes in trait anxiety.

    Self report instrument: state-trait anxiety measure for children (STAIC) - Trait scale.

    End of treatment (4 weeks), Follow up (8 weeks).

  • Changes in emotion processing.

    Performance on behavioural task: emotional dot-probe task.

    End of treatment (4 weeks), Follow up (8 weeks).

Secondary Outcomes (3)

  • Changes in depression.

    End of treatment (4 weeks), Follow up (8 weeks).

  • Changes in attention networks.

    End of treatment (4 weeks), Follow up (8 weeks).

  • Changes in nutrient intake

    End of treatment (4 weeks), Follow up (8 weeks).

Other Outcomes (4)

  • Parental anxiety: covariate of child outcome.

    Baseline, End of treatment (4 weeks), Follow up (8 weeks).

  • Parental emotion processing: covariate of child outcome.

    Baseline, End of treatment (4 weeks), Follow up (8 weeks).

  • Parent depression

    Baseline, End of treatment (4 weeks), Follow up (8 weeks).

  • +1 more other outcomes

Study Arms (2)

Treatment

ACTIVE COMPARATOR
Dietary Supplement: Galacto-oligosaccharide

Placebo

PLACEBO COMPARATOR
Dietary Supplement: Maltodextrin

Interventions

Galacto-oligosaccharideDIETARY_SUPPLEMENT

Single 7g dose daily for 28 days

Treatment
MaltodextrinDIETARY_SUPPLEMENT

Single 7g dose daily for 28 days

Placebo

Eligibility Criteria

Age6 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Typically developing, healthy male or female aged 6-14 years
  • Access to home laptop/ personal computer

You may not qualify if:

  • Current clinical levels of anxiety and/or co-morbid psychological diagnoses
  • Neuro/developmental disorders
  • Gastro-intestinal problems or disease
  • Restrictive diets (e.g., lactose intolerance, gluten free)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Surrey

Guildford, Surrey, GU2 7XH, United Kingdom

Location

Related Publications (1)

  • Johnstone N, Cohen Kadosh K. Indicators of improved emotion behavior in 6-14-year-old children following a 4-week placebo controlled prebiotic supplement intervention at home with a parent. Nutr J. 2025 Mar 1;24(1):34. doi: 10.1186/s12937-025-01098-5.

MeSH Terms

Conditions

Emotional Regulation

Interventions

4'-galactooligosaccharidemaltodextrin

Condition Hierarchy (Ancestors)

Self-ControlSocial BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2024

First Posted

February 14, 2024

Study Start

February 1, 2021

Primary Completion

December 1, 2021

Study Completion

March 1, 2022

Last Updated

February 14, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations